GlassScriptPhysician profile
Emir R Campanini
NPI 1528372315
$689.87
in general payments reported to CMS, 2019-2025
11 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.76 · 2020: $54.49 · 2021: $136 · 2023: $111 · 2024: $175 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $235.60 | 2023-2025 | Azstarys |
| Glaxosmithkline, LLC. | $161.82 | 2019-2025 | Bexsero, Penmenvy |
| Takeda Pharmaceuticals U.S.A., INC. | $89.00 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $59.20 | 2021-2024 | Vaxelis, Gardasil 9, M-M-R II |
| Tris Pharma INC | $29.33 | 2019-2024 | Dyanavel Xr |
| Seqirus USA INC | $28.35 | 2025 | Flucelvax |
| Sanofi Pasteur INC. | $22.54 | 2023 | |
| Ironshore Pharmaceuticals INC. | $19.66 | 2023 | Jornay Pm |
| Cranial Technologies, INC | $16.78 | 2020 | |
| Sobi, INC | $15.63 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $11.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emir Campanini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.